JPRN-UMIN000031451
Completed
Phase 4
Study for the effect on blood pressure and heart rate fluctuation by switching from DPP-4 inhibitor to SGLT2 inhibitor Luseogliflozin in patients with type 2 diabetes. - multicenter, prospective, randomized, open-label, parallel group, comparison study - - Luseogliflozin ABPM study
ConditionsType 2 diabetes mellitus
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Type 2 diabetes mellitus
- Sponsor
- Hokkaido University Hospital
- Enrollment
- 68
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients with taking SGLT2 inhibitors. 2\) Hypersensitivity to Luseogliflozin. 3\) Uncontrolled diabetic retinopathy 4\) Severe liver dysfunction, renal dysfunction, or heart failure 5\) Pregnancy, nursing woman or possibly pregnant woman 6\) Severe diabetic ketosis, diabetic coma 7\) Severe infection, pre and post operation , severe trauma 8\) Deficiency of insulin secretion 9\) BMI \< 22kg/m2 10\) eGFR \< 30 ml/min 11\) Patients with uncontrolled diet therapy. 12\) Patients with irregular circadian rhythm. 13\) Patients who thought to be inappropriate to enter this study for some reasons by physician's judgments
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Investigation of the effect on blood pressure improvement by home blood pressure, steps, and sleep time measurementHypertensionJPRN-UMIN000030949Business Development Center, Appliances Company, Panasonic Corporation180
Completed
N/A
Study on the effect of blood pressure suppression by single intake of test foodsHealthy AdultsJPRN-UMIN000053620Healthcare Systems Co., Ltd.4
Recruiting
N/A
Effects on Blood Pressure, Cardio-Renal Function and Vascular Endothelial Function by HyperUricemia Treatment StudyHyperuricemiaJPRN-UMIN000007350St. Lukes International Hospital50
Completed
N/A
Study into the control of blood pressure and antihypertensive medication withdrawal in haemodialysis patients by programmed reduction in dry weightCardiovascular: HypertensionCirculatory SystemHypertensionISRCTN12355432Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)40
Completed
N/A
The effect of the two drugs( Sodium Thiopental or Ketamine) duration and after ECTCondition 1: Succinylcholine Chloride. Condition 2: Sodium Thiopental. Condition 3: Ketamine.Poisoning: Skeletal muscle relaxants [neuromuscular blocking agents], Skeletal muscle relaxants [neuromuscular blocking agents]Poisoning:Intravenous anaestheticsPoisoning: Other and unspecified general anaestheticsIRCT2016030726950N1Vice Chancellor for Research of Isfahan University Of Medical Sciences64